Diagnosis and Management of Intraabdominal Infection: Guidelines by the Chinese Society of Surgical Infection and Intensive Care and the Chinese College of Gastrointestinal Fistula Surgeons
Xiuwen Wu,Jie Wu,Peige Wang,Xueling Fang,Yunsong Yu,Jianguo Tang,Yonghong Xiao,Minggui Wang,Shikuan Li,Yun Zhang,Bijie Hu,Tao Ma,Qiang Li,Zhiming Wang,Anhua Wu,Chang Liu,Menghua Dai,Xiaochun Ma,Huimin Yi,Yan Kang,Daorong Wang,Gang Han,Ping Zhang,Jianzhong Wang,Yufeng Yuan,Dong Wang,Jian Wang,Zheng Zhou,Zeqiang Ren,Yuxiu Liu,Xiangdong Guan,Jianan Ren
DOI: https://doi.org/10.1093/cid/ciaa1513
IF: 20.999
2020-11-15
Clinical Infectious Diseases
Abstract:Abstract The Chinese guidelines for IAI presented here were developed by a panel that included experts from the fields of surgery, critical care, microbiology, infection control, pharmacology, and evidence-based medicine. All questions were structured in population, intervention, comparison, and outcomes format, and evidence profiles were generated. Recommendations were generated following the principles of the Grading of Recommendations Assessment, Development, and Evaluation system or Best Practice Statement (BPS), when applicable. The final guidelines include 45 graded recommendations and 17 BPSs, including the classification of disease severity, diagnosis, source control, antimicrobial therapy, microbiologic evaluation, nutritional therapy, other supportive therapies, diagnosis and management of specific IAIs, and recognition and management of source control failure. Recommendations on fluid resuscitation and organ support therapy could not be formulated and thus were not included. Accordingly, additional high-quality clinical studies should be performed in the future to address the clinicians’ concerns.
immunology,infectious diseases,microbiology